$MIR

Here's What Key Metrics Tell Us About Mirion Technologies (MIR) Q2 Earnings

Mirion Technologies (MIR) reported Q2 revenue of $266.8M, up 19.7% year over year, and EPS of $0.12 versus $0.11 a year earlier. Revenue missed the Zacks consensus by 1.81% ($271.72M), while EPS beat by 20% versus $0.10. Segment results and adjusted EBITDA mostly met or slightly exceeded analyst estimates.

Original reporting
Published Jul 28, 2026, 10:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 29, 2026, 12:32 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Here's What Key Metrics Tell Us About Mirion Technologies (MIR) Q2 Earnings — source image
Decision brief

The 30-second read

$MIRNeutralLow
01

Why it matters

Traders can use the beat/miss split and segment adjusted EBITDA comparisons to reassess near-term earnings quality and margin trajectory, but the article lacks forward guidance or balance-sheet/cash-flow details.

02

Market read

Earnings show EPS upside versus consensus alongside a slight revenue shortfall, with nuclear and medical adjusted EBITDA both near or above estimates.

03

What to watch

The article does not include guidance, cash flow, backlog, or order trends, which are often the key follow-through drivers after earnings.

Relevance 4/10Novelty 4/10Timing: after-hours/late-day coverage of Q2 results for the quarter ended June 2026

Background

The piece summarizes Mirion Technologies’ Q2 (ended June 2026) results versus Zacks Consensus and highlights segment metrics.

Company-level read

Ticker impact

$MIRNeutralMedium confidence
Context

Mirion reported Q2 revenue of $266.8M (+19.7% YoY) and EPS $0.12, with revenue slightly below consensus but EPS above it.

Expected impact

Likely modest, two-sided reaction risk: EPS beat supports, but nuclear and safety revenue miss versus estimates may temper upside.

Evidence & confidence

Revenue was -1.81% vs consensus while EPS was +20% vs consensus; segment-level adjusted EBITDA beats in multiple areas can offset the revenue shortfall, but the nuclear and safety revenue miss is a specific caution flag.

Market effects

Segmented nuclear and medical performance details can influence how investors price demand and profitability in radiation detection and medical imaging end-markets.

No explicit regional drivers provided in the article.

No explicit global macro or international regulatory catalysts mentioned.

Counterpoint

The revenue miss is small (-1.81%) and adjusted EBITDA beats in nuclear and medical suggest profitability may be improving faster than top-line.

Key entities

  • Mirion Technologies, Inc.

    Subject of the article, reporting Q2 revenue, EPS, and segment metrics versus consensus.

Related articles

$CWMedAI 8/10

DOE Backs X-Energy Texas Reactor Project With $1 Billion Support

The U.S. Department of Energy (DOE) allocated up to $1 billion to support X-Energy's advanced nuclear reactor project in Texas. Funds will primarily support domestic supply chain partners like Curtiss-Wright, Mirion Technologies, and Fluor. The Range Nuclear Renaissance Index ETF (NUKZ) offers investors exposure to these companies.

$MIRMed

MIR Q2 Deep Dive: Margin Expansion and Nuclear Backlog Growth Offset Revenue Miss

Mirion (NYSE: MIR) reported Q2 CY2026 revenue of $266.8 million, up 19.7% year over year but slightly below analysts’ $269.6 million estimate. Non-GAAP EPS was $0.12, above the $0.10 consensus, and adjusted EBITDA was $65.3 million. Management reiterated full-year Adjusted EPS guidance of $0.52 and EBITDA guidance of $292.5 million at the midpoint, citing margin expansion and nuclear backlog growth.

$MIRMed

Mirion Technologies, Inc. (MIR): Results of Operations and Financial Condition

Mirion Technologies, Inc. (MIR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 a2026-07x28exhibit991.htm EX-99.1 Document Exhibit 99.1 News Release Mirion Announces Second Quarter 2026 Financial Results • Revenues for the second quarter increased 19.7% to $266.8 million, compared to $222.9 million in the same period in 2025. • GAAP net income was

$CEGMed

Microreactors Reach Milestones and Retailers Go Nuclear

Deployable Energy’s Unity microreactor reached criticality at Idaho National Laboratory, completing the third advanced reactor demonstration under a U.S. presidential executive order targeting three reactors by July 4, 2026. Constellation Energy (CEG) signed a long-term power purchase agreement with Walmart (WMT) for ~176 MW from Illinois’ Dresden Clean Energy Center, including uprate support.

$NVDAHighAI 9/10

Nvidia Roared. Why Didn’t All AI Stocks?

Nvidia (NVDA) reported strong Q1 earnings with $96.2B revenue, up 106% YoY, and guided $108B for Q2. CEO Jensen Huang highlighted AI's inflection point. Shares rose 8%. Potential tariffs on semiconductors may impact the AI sector. Savers Value Village (SVV) is using AI to improve margins in the thrift industry.